Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy.

Mean CAV-free survival was 47.5 months (95% CI [43.1–51.8]) ( Figure 1 ). Although the sample was substantively smaller and the follow-up time substantively shorter in the group that did not receive statin therapy ( Table 1 ), treatment with a statin after transplantation showed a trend towards improved CAV-free survival compared with those who did not receive statin therapy (p=0.055).

also in 53,322 other papers